アミノグリコシド: インダクション,用量,モニタリングに関する最新情報
Hazel Moore1,2,3,4,5,6, Daniel Yeoh1,2,3,4,5,6, Carly Hughes1,2,3,4,5,6
1Therapeutic Guidelines Limited, Melbourne.
Australian prescriber
|August 27, 2025
まとめ
新しいオーストラリアのガイドラインは,成人におけるアミノグリコシドの投与について,痩せた体重を強調しています. 治療薬のモニタリングは,曲線下の領域に焦点を当てて,48時間以上の治療に不可欠です.
科学分野:
- 薬理学について
- 感染症
- クリニカル・セラピー
背景:
- アミノグリコシド (ジェンタミシン,トブラミシン,アミカシン) は,重度のグラム陰性感染症の治療に不可欠な親腸内抗生物質である.
- これらの抗生物質は,オーストラリアで迅速な殺菌作用と低耐性率を示しています.
- 抗生物質療法に関する確立されたガイドラインは,最近更新されました.
研究 の 目的:
- アミノグリコシドの使用に関する最新のガイドラインの概要
- 最適な投与戦略と薬物の選択を詳細に説明する.
- グラム陰性感染症の管理に関する新しい推奨事項について臨床医に知らせる.
主な方法:
- 治療ガイドラインのレビューと更新: 抗生物質 (2025年3月)
- 大人のアミノグリコシド用量に関する新しい推奨事項の追加
- 投与量調整のための計算機の開発
主要な成果:
- 大人のアミノグリコシドの投与量は,痩せた体重に基づいています.
- 精密な用量計算に役立つ計算機が用意されています.
- 治療薬のモニタリングは48時間以上の治療に推奨されます.
結論:
- 更新されたガイドラインは,アミノグリコシドの最適化用量と選択戦略を提供します.
- 痩せた体重は成人用薬の推奨基準です.
- アミノグリコシドの長期治療では,濃度-時間曲線の下の領域のモニタリングが推奨されます.
関連する概念動画
01:11Renal Failure: Dose Adjustments
153
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
153
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
01:15Drug Dosage Regimen: Overview
3.8K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.8K
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
40
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
40
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.7K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.7K
01:26Heart Failure Drugs: Inotropic Agents
717
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
717